Spark Therapeutics will invest $575M in a cell and gene therapy innovation center on Drexel’s campus

Spark Therapeutics, one of the first and now largest cell and gene therapy companies in the Philadelphia region, announced Friday that it was investing $575 million into a 500,000-square-foot manufacturing facility.